Ogoudjobi Om, M. S. Lokossou, Veronique Tognifode, M. Aboubakar, A. Kerekou, E. Tandjiekpon, Denakpo Jl, R. Perrin
{"title":"Randomized Study Comparing Two Gestational Diabetes Screening Strategies in a Reference Maternity Hospital in Southern Benin","authors":"Ogoudjobi Om, M. S. Lokossou, Veronique Tognifode, M. Aboubakar, A. Kerekou, E. Tandjiekpon, Denakpo Jl, R. Perrin","doi":"10.4172/2090-7214.1000295","DOIUrl":null,"url":null,"abstract":"Objective: The objective of this work is to compare two gestational diabetes screening strategies. Patients and methods: We conducted a comparative randomized study that screened gestational diabetes on pregnant women who are between 24th and 28th weeks of amenorrhea. We conducted the trials either by measuring fasting glucose values or by a glucose tolerance test performed two hours after oral loading of 75 g glucose (WHO test). The study involved 580 pregnant women (290 for each type of trial) who came for antenatal appointment at the reference maternity hospital in Porto-Novo (Benin) between February 2nd, 2015 and January 31st, 2017. Results: We detected 26 cases (9%) of gestational diabetes by the “fasting glucose value measurement method” as compared to the 18 cases (6.2%) detected by the WHO test, leading to a p-value of 0.209. The two types of test were equally relevant: Sensitivity (59.09% vs. 40.91%), specificity (50.75% vs. 49.25%), positive predictive value (8.97% vs. 6.21%), and predictive value negative (93.79% vs. 91.03%). All pregnant women tested “negative” between their 24th and their 28th weeks of amenorrhea, were tested again during the 32nd week of amenorrhea, using the WHO test method and no new case of gestational diabetes was detected. Conclusion: Fasting glucose value measurement method can be an alternative method for gestational diabetes screening in a population where the WHO test is not available.","PeriodicalId":92765,"journal":{"name":"Clinics in mother and child health","volume":" ","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics in mother and child health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2090-7214.1000295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objective: The objective of this work is to compare two gestational diabetes screening strategies. Patients and methods: We conducted a comparative randomized study that screened gestational diabetes on pregnant women who are between 24th and 28th weeks of amenorrhea. We conducted the trials either by measuring fasting glucose values or by a glucose tolerance test performed two hours after oral loading of 75 g glucose (WHO test). The study involved 580 pregnant women (290 for each type of trial) who came for antenatal appointment at the reference maternity hospital in Porto-Novo (Benin) between February 2nd, 2015 and January 31st, 2017. Results: We detected 26 cases (9%) of gestational diabetes by the “fasting glucose value measurement method” as compared to the 18 cases (6.2%) detected by the WHO test, leading to a p-value of 0.209. The two types of test were equally relevant: Sensitivity (59.09% vs. 40.91%), specificity (50.75% vs. 49.25%), positive predictive value (8.97% vs. 6.21%), and predictive value negative (93.79% vs. 91.03%). All pregnant women tested “negative” between their 24th and their 28th weeks of amenorrhea, were tested again during the 32nd week of amenorrhea, using the WHO test method and no new case of gestational diabetes was detected. Conclusion: Fasting glucose value measurement method can be an alternative method for gestational diabetes screening in a population where the WHO test is not available.
目的:本研究的目的是比较两种妊娠糖尿病筛查策略。患者和方法:我们进行了一项比较随机研究,对闭经24至28周的孕妇进行妊娠糖尿病筛查。我们通过测量空腹血糖值或在口服75克葡萄糖两小时后进行葡萄糖耐量试验(世卫组织试验)来进行试验。该研究涉及580名孕妇(每种试验290名),这些孕妇于2015年2月2日至2017年1月31日期间在波尔图-诺沃(贝宁)的参考妇产医院进行产前预约。结果:采用“空腹血糖测定法”检测妊娠期糖尿病26例(9%),WHO检测18例(6.2%),p值为0.209。两种检测的相关性相等:敏感性(59.09% vs. 40.91%)、特异性(50.75% vs. 49.25%)、阳性预测值(8.97% vs. 6.21%)和阴性预测值(93.79% vs. 91.03%)。所有孕妇在闭经24周至28周期间检测结果均为“阴性”,在闭经32周期间使用世卫组织检测方法再次检测,未发现新的妊娠糖尿病病例。结论:空腹血糖值测量法可作为妊娠糖尿病筛查的替代方法,在人群中WHO测试是不可用的。